hydroxychloroquine has been researched along with Canine Diseases in 3 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This is the first study to evaluate the use of a TNF-α inhibitor for canine lupus and the first to address the safety of long-term administration of hydroxychloroquine, albeit in a small number of dogs." | 2.75 | Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment. ( Brown, DC; Casal, ML; Mauldin, EA; Morris, DO, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gustafson, DL | 1 |
| Viola, LO | 1 |
| Towers, CG | 1 |
| Das, S | 1 |
| Duval, DL | 1 |
| Van Eaton, KM | 1 |
| Mauldin, EA | 1 |
| Morris, DO | 1 |
| Brown, DC | 1 |
| Casal, ML | 1 |
| Oberkirchner, U | 1 |
| Linder, KE | 1 |
| Olivry, T | 1 |
1 trial available for hydroxychloroquine and Canine Diseases
| Article | Year |
|---|---|
Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment.
Topics: Adalimumab; Animals; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Cyclosporine; Dog Dise | 2010 |
2 other studies available for hydroxychloroquine and Canine Diseases
| Article | Year |
|---|---|
Sensitivity of osteosarcoma cell lines to autophagy inhibition as determined by pharmacologic and genetic manipulation.
Topics: Animals; Antineoplastic Agents; Autophagy; Cell Line, Tumor; Dog Diseases; Dogs; Humans; Hydroxychlo | 2023 |
Successful treatment of a novel generalized variant of canine discoid lupus erythematosus with oral hydroxychloroquine.
Topics: Administration, Oral; Animals; Antirheumatic Agents; Dog Diseases; Dogs; Female; Hydroxychloroquine; | 2012 |